May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 14, 2025

Leading Cause of Death in Residents, Study

Study shows high suicide rates during training transitions, with pathology residents facing the highest suicide risk compared with other specialties.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

August 07, 2024

Cytology: the Backbone of Modern Pathology?

Why we need to standardize and improve training models to empower the next generation of expert cytopathologists

The Pathologist

October 15, 2024

Novel Anti-Acetylated Tau Antibodies Offer New Insights and Potential Therapies for Alzheimer's Disease

With the development of monoclonal antibodies against acetylated tau, researchers unlock new possibilities for Alzheimer's diagnostics and treatment.

Conexiant

September 26, 2024

T Cell Spatial Patterns Linked to CRC Survival

Study links shorter T-cell proximity to cancer cells with improved survival rates in colorectal cancer.

Conexiant

December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant